KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares Issued
Ratios

Nektar Therapeutics (NKTR) Long-Term Debt Repayments (2016 - 2017)

Historic Long-Term Debt Repayments for Nektar Therapeutics (NKTR) over the last 8 years, with Q4 2017 value amounting to $3.0 million.

  • Nektar Therapeutics' Long-Term Debt Repayments rose 42231.99% to $3.0 million in Q4 2017 from the same period last year, while for Sep 2018 it was $3.0 million, marking a year-over-year increase of 894.43%. This contributed to the annual value of $5.1 million for FY2017, which is 1369.22% down from last year.
  • Latest data reveals that Nektar Therapeutics reported Long-Term Debt Repayments of $3.0 million as of Q4 2017, which was up 42231.99% from $790000.0 recorded in Q3 2017.
  • Nektar Therapeutics' Long-Term Debt Repayments' 5-year high stood at $3.0 million during Q4 2017, with a 5-year trough of $569000.0 in Q4 2016.
  • Over the past 5 years, Nektar Therapeutics' median Long-Term Debt Repayments value was $876500.0 (recorded in 2014), while the average stood at $1.1 million.
  • Data for Nektar Therapeutics' Long-Term Debt Repayments shows a peak YoY increase of 42231.99% (in 2017) and a maximum YoY decrease of 6442.25% (in 2017) over the last 5 years.
  • Over the past 5 years, Nektar Therapeutics' Long-Term Debt Repayments (Quarter) stood at $791000.0 in 2013, then increased by 21.11% to $958000.0 in 2014, then skyrocketed by 44.99% to $1.4 million in 2015, then tumbled by 59.04% to $569000.0 in 2016, then skyrocketed by 422.32% to $3.0 million in 2017.
  • Its Long-Term Debt Repayments stands at $3.0 million for Q4 2017, versus $790000.0 for Q3 2017 and $756000.0 for Q2 2017.